NBRV logo

Nabriva Therapeutics (NBRV) Retained Earnings

Annual Retained Earnings

-$652.86 M
-$57.19 M-9.60%

December 31, 2022


Summary


Performance

NBRV Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNBRVbalance sheetmetrics:

Quarterly Retained Earnings

-$661.56 M
-$8.70 M-1.33%

March 31, 2023


Summary


Performance

NBRV Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNBRVbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

NBRV Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-9.6%-8.9%
3 y3 years-36.9%-32.3%
5 y5 years-133.8%-126.1%

NBRV Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year+9.6%at low+11.1%at low
5 y5-year+36.9%at low+38.8%at low
alltimeall time+466.0%at low+478.1%at low

Nabriva Therapeutics Retained Earnings History

DateAnnualQuarterly
Mar 2023
-
-$661.56 M(+1.3%)
Dec 2022
-$652.86 M(+9.6%)
-$652.86 M(+3.6%)
Sep 2022
-
-$630.08 M(+1.9%)
Jun 2022
-
-$618.57 M(+1.8%)
Mar 2022
-
-$607.50 M(+2.0%)
Dec 2021
-$595.68 M(+9.1%)
-$595.68 M(+2.2%)
Sep 2021
-
-$582.61 M(+1.9%)
Jun 2021
-
-$571.96 M(+2.1%)
Mar 2021
-
-$560.21 M(+2.6%)
Dec 2020
-$546.23 M(+14.6%)
-$546.23 M(+3.4%)
Sep 2020
-
-$528.39 M(+2.5%)
Jun 2020
-
-$515.44 M(+3.1%)
Mar 2020
-
-$500.00 M(+4.9%)
Dec 2019
-$476.74 M(+21.0%)
-$476.74 M(+5.1%)
Sep 2019
-
-$453.70 M(+4.1%)
Jun 2019
-
-$435.90 M(+5.2%)
Mar 2019
-
-$414.19 M(+5.1%)
DateAnnualQuarterly
Dec 2018
-$393.98 M(+41.1%)
-$393.98 M(+8.5%)
Sep 2018
-
-$363.15 M(+17.0%)
Jun 2018
-
-$310.33 M(+6.1%)
Mar 2018
-
-$292.54 M(+4.8%)
Dec 2017
-$279.20 M(+36.3%)
-$279.20 M(+8.7%)
Sep 2017
-
-$256.94 M(+9.5%)
Jun 2017
-
-$234.67 M(+6.6%)
Mar 2017
-
-$220.07 M(+7.4%)
Dec 2016
-$204.84 M(+19.5%)
-$204.84 M(+16.1%)
Sep 2016
-
-$176.36 M(+8.6%)
Jun 2016
-
-$162.39 M(+8.0%)
Mar 2016
-
-$150.40 M(-12.3%)
Dec 2015
-$171.43 M(+45.5%)
-$171.43 M(+28.7%)
Sep 2015
-
-$133.21 M(+7.0%)
Jun 2015
-
-$124.49 M(+8.8%)
Mar 2015
-
-$114.44 M(-2.9%)
Dec 2014
-$117.84 M(+2.2%)
-$117.84 M
Dec 2013
-$115.34 M
-

FAQ

  • What is Nabriva Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Nabriva Therapeutics?
  • What is Nabriva Therapeutics annual retained earnings year-on-year change?
  • What is Nabriva Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Nabriva Therapeutics?
  • What is Nabriva Therapeutics quarterly retained earnings year-on-year change?

What is Nabriva Therapeutics annual retained earnings?

The current annual retained earnings of NBRV is -$652.86 M

What is the all time high annual retained earnings for Nabriva Therapeutics?

Nabriva Therapeutics all-time high annual retained earnings is -$115.34 M

What is Nabriva Therapeutics annual retained earnings year-on-year change?

Over the past year, NBRV annual retained earnings has changed by -$57.19 M (-9.60%)

What is Nabriva Therapeutics quarterly retained earnings?

The current quarterly retained earnings of NBRV is -$661.56 M

What is the all time high quarterly retained earnings for Nabriva Therapeutics?

Nabriva Therapeutics all-time high quarterly retained earnings is -$114.44 M

What is Nabriva Therapeutics quarterly retained earnings year-on-year change?

Over the past year, NBRV quarterly retained earnings has changed by -$54.07 M (-8.90%)